The aim of this paper is to evaluate clinically relevant quality assurance (QA) tests for RapidArc prostate patients. 26 plans were verified by the COMPASS system that provides an independent angle response and a reconstruction of dose distribution in patient CT model. Plan data were imported from treatment planning system via DICOM. The fluencies, measured by a 2D detector, were used by COMPASS to forward calculate dose in CT patients and reconstruct dose-volume-histogram (DVH). The gamma analysis was performed, using both the criteria 3%-3-mm and 2%-2 mm, for the whole grid patient and the per-structure volume. A DVH-based analysis was accomplished for target and organs-at-risk (OAR). The correlation between gamma passing rates and DVH discrepancies was performed using Pearson's test. Sensitivity, specificity and accuracy of whole and per-structure gamma method were calculated.
No significant DVH deviation was observed for target and OAR. Weak correlation between gamma passing rates and dosimetric deviations was observed, all significant r-values were negative. The whole gamma method shows lack of sensitivity to detect dosimetric deviations >5%. Instead, a better balance between sensitivity and specificity was obtained employing per structure gamma both with 3%-3 mm and 2%-2 mm criteria.
Because of the poor correlation between DVH goals and gamma passing rates, we encourage the DVH-based gamma passing rates, when it is possible. At least, a gamma method specific for structure was strongly suggested.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Physica Medica: European Journal of Medical Physics
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Volumetric modulated arc therapy: IMRT in a single gantry arc.Med Phys. 2008; 35: 310-317
- RapidArc volumetric modulated therapy planning for prostate cancer.Acta Oncol. 2009; 48: 227-232
- Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.Int J Radiat Oncol Biol Phys. 2008; 72: 996-1001
- Volumetric arc therapy (VMAT) reduces treatment time compared to conventional IMRT (cIMRT) while maintaining similar plan quality in whole pelvic gynecologic radiotherapy.Int J Radiat Oncol Biol Phys. 2008; 72: S366
- Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study.Phys Med. 2013; : 1-6
- A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery.Med Phys. 2003; 30: 870-879
- Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array.Radiat Oncol. 2011; 6: 21
- Volumetric modulated arc therapy: effective and efficient end-to-end patient specific quality assurance.Int J Radiat Oncol Biol Phys. 2012; 82: 1567-1574
- Quality assurance of Rapid Arc treatments: performances and pre-clinical verifications of a planar detector (MapCHECK2).Phys Med. 2013; : 1-7
- Quality assurance of volumetric modulated arc therapy: evaluation and comparison of different dosimetric systems.Med Phys. 2011; 38: 612-621
- MapCHECK used for rotational IMRT measurements: step-and-shoot, TomoTherapy, RapidArc.Med Phys. 2010; 37: 2837-2846
- Evaluation of a biplanar diode array dosimeter for quality assurance of step-and-shoot IMRT.J Appl Clin Med Phys. 2009; 10: 3080
- Characterization and clinical evaluation of a novel IMRT quality assurance system.J Appl Clin Med Phys. 2009; 10: 2928
- Calibration of a novel four-dimensional diode array.Med Phys. 2010; 37: 108-115
- Evaluation of the ArcCHECK QA system for IMRT and VMAT verification.Phys Med. 2013; 29: 295-303
- Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors.Med Phys. 2011; 38: 1037-1044
- Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.Med Phys. 2012; 39: 7626-7634
- Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies.Phys Med Biol. 2010; 55: 5619-5633
- Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.Int J Radiat Oncol Biol Phys. 2011; 81: 1168-1175
- Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.Radiother Oncol. 2011; 100: 446-452
- Collapsed cone convolution and analytical anisotropic algorithm dose calculations compared to VMC++ Monte Carlo simulations in clinical cases.Phys Med Biol. 2007 Jul 7; 52: 3679-3691
- The impact of photon dose calculation algorithms on expected dose distributions in lungs under different respiratory phases.Phys Med Biol. 2008 May 7; 53: 2375-2390
- Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.Med Phys. 2011; 38: 5477
- Dosimetric verification of a commercial collapsed cone algorithm in simulated clinical situations.Radiother Oncol. 2004; 73: 79-88
- Patient QA systems for rotational radiation therapy: a comparative experimental study with intentional errors.Med Phys. 2013; 40: 031716
- Efficient and reliable 3D dose quality assurance for IMRT by combining independent dose calculations with measurements.Med Phys. 2013 Feb; 40: 021710
Published online: January 31, 2014
Accepted: January 11, 2014
Received in revised form: January 10, 2014
Received: August 19, 2013
© 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Inc. All rights reserved.